據歐盟食品安全局（EFSA）消息，2024年9月27日，歐盟食品安全局就活性物質氟噻草胺（flufenacet）的農藥風險評估發布同行評審。
經過評估，將氟噻草胺作為除草劑用在冬季谷物的基礎上，歐盟食品安全局提出了適用于監管風險評估和第12條MRL審查后驗證數據評估的可靠端點，列出了監管框架要求的缺失信息，發現問題時會進行報告。部分原文報道如下：
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State Poland and co-rapporteur Member State France for the pesticide active substance flufenacet are reported. In addition, the assessment of the confirmatory data following the Article 12 maximum residue limit (MRL) review of Regulation (EC) No 396/2005 is also reported. The context of the peer review was that required by Commission Implementing Regulation (EU) No 844/2012. The conclusions were reached on the basis of the evaluation of the representative use of flufenacet as a herbicide on winter cereals. Confirmatory data following the Article 12 MRL review were assessed. The reliable end points, appropriate for use in regulatory risk assessment and the assessment of confirmatory data following the Article 12 MRL review, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are reported where identified.
經過評估，將氟噻草胺作為除草劑用在冬季谷物的基礎上，歐盟食品安全局提出了適用于監管風險評估和第12條MRL審查后驗證數據評估的可靠端點，列出了監管框架要求的缺失信息，發現問題時會進行報告。部分原文報道如下：
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State Poland and co-rapporteur Member State France for the pesticide active substance flufenacet are reported. In addition, the assessment of the confirmatory data following the Article 12 maximum residue limit (MRL) review of Regulation (EC) No 396/2005 is also reported. The context of the peer review was that required by Commission Implementing Regulation (EU) No 844/2012. The conclusions were reached on the basis of the evaluation of the representative use of flufenacet as a herbicide on winter cereals. Confirmatory data following the Article 12 MRL review were assessed. The reliable end points, appropriate for use in regulatory risk assessment and the assessment of confirmatory data following the Article 12 MRL review, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are reported where identified.
